Etienne Schneider, Luxembourg’s health minister, said that the current drug policy which has been in existence in the country for the past 50 years hasn’t had the desired effect because prohibition only served to make marijuana more appealing to the youth. He added that he hoped that the citizens of Luxembourg would all become more open-minded towards drugs.
This week, the UK’s National Institute for Health and Care Excellence declined to approve medicinal cannabis for use in children with severe epilepsy on the NHS, saying there was not enough evidence to support its use. In 2018, however, the US Food and Drug Administration approved a cannabidiol for use in children with two types of severe epilepsy. So what is the situation in Australia, and is there evidence to support all the hype?
Cannabis and cannabinoids have been used medically and recreationally for thousands of years and recently there has been a growing body of research in this area. With increased access now that medical marijuana is available in many jurisdictions, patients and providers want to know more about the evidence for benefits and risks of cannabinoid use.